Invention Grant
- Patent Title: Method of treatment with lactic acid bacteria
-
Application No.: US16481643Application Date: 2018-01-31
-
Publication No.: US11660321B2Publication Date: 2023-05-30
- Inventor: Dong-Hyun Kim , Myung Joo Han
- Applicant: UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY , NAVIPHARM CO., LTD.
- Applicant Address: KR Gyeonggi-do
- Assignee: UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY,NAVIPHARM CO., LTD.
- Current Assignee: UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY,NAVIPHARM CO., LTD.
- Current Assignee Address: KR Gyeonggi-Do; KR Gyeonggi-Do
- Agency: Harness, Dickey & Pierce, P.L.C.
- Priority: KR 20170013632 2017.01.31
- International Application: PCT/KR2018/001359 2018.01.31
- International Announcement: WO2018/143678A 2018.08.09
- Date entered country: 2019-07-29
- Main IPC: A61K35/745
- IPC: A61K35/745 ; A23L7/104 ; A23L33/135 ; A61P37/06 ; A61P37/08 ; A61P29/00 ; C12N1/20 ; A21D8/04 ; A23C9/127 ; A23L2/02 ; A23L2/52 ; A61K35/747 ; C12R1/25 ; A61K35/00

Abstract:
A particular Bifidobacterium spp. strain or particular Lactobacillus spp. strain according to the present invention is isolated from excrement of a human or cabbage kimchi, and thus is highly safe and has physiological activities such as an immunity regulatory effect and an inflammation reaction inhibiting effect. Therefore, the particular Bifidobacterium spp. strain or particular Lactobacillus spp. strain according to the present invention may be used as a material for regulating immunity and inhibiting inflammation reactions, and may be also used as a functional food and drug material useful for preventing, alleviating or treating rhinitis, atopy, asthma, etc. which are allergic diseases.
Public/Granted literature
- US20220323515A1 NOVEL LACTIC ACID BACTERIA AND USE THEREOF Public/Granted day:2022-10-13
Information query
IPC分类: